5,5-dimethyl-1-pyrroline-1-oxide and oxidopamine

5,5-dimethyl-1-pyrroline-1-oxide has been researched along with oxidopamine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cowan, DL; Oldfield, FF; Sun, AY1
Burke, WJ; Ebadi, M; el-Sayed, MA; Folks, DG; Hiramatsu, M1
Ashihara, E; Inden, M; Kitamura, Y; Takata, K; Yasui, H; Yoshimoto, K1

Other Studies

3 other study(ies) available for 5,5-dimethyl-1-pyrroline-1-oxide and oxidopamine

ArticleYear
The involvement of ethanol in the free radical reaction of 6-hydroxydopamine.
    Neurochemical research, 1991, Volume: 16, Issue:1

    Topics: Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Ethanol; Ferrous Compounds; Free Radicals; Glutathione; Hydrogen Peroxide; Hydroxides; Hydroxydopamines; Hydroxyl Radical; Lipid Peroxidation; Mannitol; Oxidopamine; Sodium-Potassium-Exchanging ATPase; Spin Labels; Vitamin E

1991
Metallothionein isoforms provide neuroprotection against 6-hydroxydopamine-generated hydroxyl radicals and superoxide anions.
    Proceedings of the Western Pharmacology Society, 1998, Volume: 41

    Topics: Animals; Anions; Brain; Cells, Cultured; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Hydroxyl Radical; Metallothionein; Mice; Mitochondria; Neuroprotective Agents; Oxidopamine; Protein Isoforms; Spin Labels; Superoxides

1998
Detoxification of 6-hydroxydopamine-induced dopaminergic neurodegeneration by 5,5-dimethyl-1-pyrroline N-oxide, a radical trapper, in hemiparkinsonian rats.
    Biological & pharmaceutical bulletin, 2012, Volume: 35, Issue:9

    Topics: Animals; Antioxidants; Behavior, Animal; Cyclic N-Oxides; Disease Models, Animal; Dose-Response Relationship, Drug; Hydroxyl Radical; Iron; Male; Mental Disorders; Oxidative Stress; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar; Substantia Nigra; Tyrosine 3-Monooxygenase

2012